Guibourtinidol-(4alpha→8)-epicatechin for COVID-19

 Guibourtinidol-(4alpha→8)-epicatechin has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 200+ treatments. We have not reviewed guibourtinidol-(4alpha→8)-epicatechin in detail.
Ferreira Júnior et al., An In Silico Investigation of Brazilian Green Propolis Extracts as Potential Treatment for COVID-19, ACS Omega, doi:10.1021/acsomega.5c02121